Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Mon 22:59
BRIEF-Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing Oct 19 (Reuters) - Integra LifeSciences Holdings Corporation IART.O:
INTEGRA LIFESCIENCES - ENTERS AMENDED AND RESTATED CREDIT AGREEMENT ON OCT 19, 2026 - SEC FILING
INTEGRA LIFESCIENCES - CREDIT AGREEMENT PROVIDES UP TO $1.65 BILLION AGGREGATE PRINCIPAL AMOUNT - SEC FILING
INTEGRA LIFESCIENCES - NOTES MATURE ON NOVEMBER 1, 2033 UNLESS EARLIER REPURCHASED OR REDEEMED - SEC FILING
Source text: [ID:n0001193125-26-425271]
Further company coverage: IART.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes